Discovery and chemical optimisation of a potent, Bi-cyclic antimicrobial inhibitor of Escherichia coli PBP3

Penicillin binding proteins (PBPs) are well validated antimicrobial targets, but the prevalence of β-lactamase driven resistance and, more rarely, target-based mutations, necessitates new classes of PBP-targeting drugs. Here we describe the discovery and optimisation of bicyclic peptide (Bicycle<sup>®</sup>) inhibitors of E. coli PBP3 (EcPBP3) using a proprietary phage display platform, and their conjugation to linear antimicrobial peptides to confer outer membrane permeation. These molecules exhibited high-affinity binding to E. coli PBP3 and a viable spectrum of killing activity against clinically relevant species of the Enterobacterales. X-ray crystallography was used to explore the mode of binding to PBP3, enabling increased target affinity and improvement of in vitro stability. These compounds bind to the transpeptidase active site cleft of PBP3 and represent, to our knowledge, a novel non-β-lactam chemical class of high affinity, non-covalent penicillin binding protein inhibitors. This work demonstrates an approach to rapidly find binders to antimicrobial targets, combined with an entry mechanism to provide access to the Gram negative cell.

Authors

Institutions

Publication Details

Journal
Communications Biology
Published
2025-05-28
DOI
https://doi.org/10.1038/s42003-025-08246-x
Citations
4
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
2.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery and chemical optimisation of a potent, Bi-cyclic antimicrobial inhibitor of Escherichia coli PBP3

Matthew Balmforth, David I. Roper, Celia Kessler, Michael J. Skynner et al.
4 citations
Communications Biology
Antibiotic Resistance in Bacteria
2.36
article

Discovery and chemical optimisation of a potent, Bi-cyclic antimicrobial inhibitor of Escherichia coli PBP3

Matthew Balmforth, David I. Roper, Celia Kessler, Michael J. Skynner, Dom Bellini, Adrian J. Lloyd, Rachel Dods, Steven J. Stanway, Nick Lewis, Catherine E Rowland, Nikolaos Bournakas, Hector Newman, Paul Beswick, Katerine Van Rietschoten, Tazmin T. Martin, Christopher G. Dowson, James M. Wagstaff, Michael J. Dawson
article en
4 citations

Abstract

Penicillin binding proteins (PBPs) are well validated antimicrobial targets, but the prevalence of β-lactamase driven resistance and, more rarely, target-based mutations, necessitates new classes of PBP-targeting drugs. Here we describe the discovery and optimisation of bicyclic peptide (Bicycle<sup>®</sup>) inhibitors of E. coli PBP3 (EcPBP3) using a proprietary phage display platform, and their conjugation to linear antimicrobial peptides to confer outer membrane permeation. These molecules exhibited high-affinity binding to E. coli PBP3 and a viable spectrum of killing activity against clinically relevant species of the Enterobacterales. X-ray crystallography was used to explore the mode of binding to PBP3, enabling increased target affinity and improvement of in vitro stability. These compounds bind to the transpeptidase active site cleft of PBP3 and represent, to our knowledge, a novel non-β-lactam chemical class of high affinity, non-covalent penicillin binding protein inhibitors. This work demonstrates an approach to rapidly find binders to antimicrobial targets, combined with an entry mechanism to provide access to the Gram negative cell.

Communications BiologyVol. 8(1)
University of Warwick (GB), Granta Design (United Kingdom) (GB), Bicycle Therapeutics (United Kingdom) (GB)
University of Oklahoma, UK Research and Innovation, University of Warwick, Samsung Biomedical Research Institute, Innovate UK
Life in Land
Openalex Percentile: Top 11%
Antibiotic Resistance in Bacteria
2.36
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.